Skip to the story
Morning ColumnFree letter

Current News · Sourced report

Platelet Factor 4 (PF4) Radioimmunoassay Recall: Instrumentation Laboratories Removes HemosIL AcuStar HIT-IgG(PF4-H)

Product performance issue may lead to a false negative result which will delay recognition of heparin-induced thrombocytopenia.

News Desk · Oct 30, 2026 · U.S. Food and Drug Administration

Open the source

This item is a public release from the U.S. Food and Drug Administration. The source date is Oct 30, 2026. The next paragraph is the agency's own short text. Morning Column did not rewrite it.

Product performance issue may lead to a false negative result which will delay recognition of heparin-induced thrombocytopenia.

The full release is on the source page. This page is not personal medical advice.

This page is general information from the sources below. It is not personal medical advice, a diagnosis, or a treatment plan. Talk with a qualified clinician about your own health. Read the disclaimer.

References

  1. U.S. Food and Drug Administration. Platelet Factor 4 (PF4) Radioimmunoassay Recall: Instrumentation Laboratories Removes HemosIL AcuStar HIT-IgG(PF4-H). Oct 30, 2026.

See a factual error? Write to contact@morningcolumn.com. The corrections log is public.